Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ReQuip 250microgram tablets
0409010H0BBAAAA
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 63 |
|
Reminyl 4mg/ml oral solution
0411000F0BBAEAD
|
Reminyl | Galantamine | Central Nervous System | 62 |
|
Syndol Headache Relief tablets
0407010X0BEACAJ
|
Syndol | Paracetamol combined preparations | Central Nervous System | 62 |
|
Victanyl 100micrograms/hour transdermal patches
0407020A0BMADAH
|
Victanyl | Fentanyl | Central Nervous System | 62 |
|
Adepend 50mg tablets
0410030E0BEAAAA
|
Adepend | Naltrexone hydrochloride | Central Nervous System | 61 |
|
Clonazepam 500micrograms/5ml oral liquid
0408010F0AABEBE
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | 61 |
|
Methylphenidate 5mg/5ml oral solution
0404000M0AAAFAF
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 61 |
|
Neupro 1mg/24hours transdermal patches
0409010Z0BBAFAF
|
Neupro | Rotigotine | Central Nervous System | 61 |
|
Yemex 75micrograms/hour transdermal patches
0407020A0BVADAG
|
Yemex | Fentanyl | Central Nervous System | 61 |
|
Fentanyl 800microgram lozenges
0407020A0AAALAL
|
Fentanyl | Fentanyl | Central Nervous System | 60 |
|
Carlosafine 70micrograms/hour transdermal patches
0407020B0BTACAG
|
Carlosafine | Buprenorphine | Central Nervous System | 59 |
|
Fycompa 0.5mg/ml oral suspension
0408010AKBBAGAJ
|
Fycompa | Perampanel | Central Nervous System | 59 |
|
Gabapentin 100mg/5ml oral suspension
0408010G0AAAGAG
|
Gabapentin | Gabapentin | Central Nervous System | 59 |
|
Melatonin 2mg modified-release capsules
0401010ADAACHCH
|
Melatonin | Melatonin | Central Nervous System | 59 |
|
Migril tablets
0407041F0BGAAAJ
|
Migril | Ergotamine tartrate | Central Nervous System | 59 |
|
Morphine 200mg modified-release tablets
0407020Q0AAAGAG
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 59 |
|
Naltrexone 5mg/5ml oral suspension
0410030E0AAATAT
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 59 |
|
Quetiapine 100mg/5ml oral liquid
0402010ABAAAMAM
|
Quetiapine | Quetiapine | Central Nervous System | 59 |
|
Trevicta 350mg/1.75ml prolonged-release inj pf syringes
0402020ABBCACAH
|
Trevicta | Paliperidone | Central Nervous System | 59 |
|
Denzapine 100mg tablets
0402010C0BCABAB
|
Denzapine | Clozapine | Central Nervous System | 58 |
|
Prefibin 2mg sublingual tablets
0410030A0BCABAD
|
Prefibin | Buprenorphine hydrochloride | Central Nervous System | 58 |
|
Xyrem 500mg/ml oral solution
0401010ACBBAAAA
|
Xyrem | Sodium oxybate | Central Nervous System | 58 |
|
Buprenorphine 96mg/0.27ml prolonged-release inj pfs
0410030A0AAATAT
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 57 |
|
Tolcapone 100mg tablets
0409010S0AAAAAA
|
Tolcapone | Tolcapone | Central Nervous System | 57 |
|
Tramadol 50mg/5ml oral solution sugar free
040702040AABEBE
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | 57 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.